Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. RH
5. SPY
6. NVDA
7. MSFT
8. MH
9. DLMAF
10. DOL:CN

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results

Corvus Pharmaceuticals, Inc. (CRVS) Reports In-Line Q2 EPS

August 8, 2023 4:05 PM EDT

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) reported Q2 EPS of ($0.14), in-line with the analyst estimate of ($0.14).

For earnings history and earnings-related data on Corvus Pharmaceuticals, Inc. (CRVS) click here.

... More